publication venue for
- CD28-CD57+T cells from head and neck cancer patients produce high levels of cytotoxic granules and type II interferon but are not senescent 2024
- ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancer 2020
- Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer 2018
- T cell receptor richness in peripheral blood increases after cetuximab therapy and correlates with therapeutic response 2018
- Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer 2017
- Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk 2016